Timing and implications for immune response to vaccine in SARS-CoV-2 breakthrough infections

COVID-19 vaccines elicit a strong anti-S antibodies response. We aim to describe antibody titers in peri-vaccination SARS-CoV-2 infections. This is a retrospective longitudinal single-cohort study. Serological tests were performed at the time of the first SARS-CoV-2 vaccine dose (T0) and 60 (T1), 12...

Descripción completa

Detalles Bibliográficos
Autores principales: Arsuffi, Stefania, Sansone, Emanuele, Focà, Emanuele, Storti, Samuele, Diaferia, Teresa, Bonfanti, Carlo, Terlenghi, Luigina, Caruso, Arnaldo, Sala, Emma, Castelli, Francesco, De Palma, Giuseppe, Quiros-Roldan, Eugenia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122568/
https://www.ncbi.nlm.nih.gov/pubmed/37152764
http://dx.doi.org/10.1016/j.isci.2023.106716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122568/
https://www.ncbi.nlm.nih.gov/pubmed/37152764
http://dx.doi.org/10.1016/j.isci.2023.106716

Ejemplares similares